| Ytd | 87.40% | |
| 1y | 752.23% |
| Open | 7.06 | Prev Close | 7.21 | Low | 6.82 | High | 7.15 | Mkt Cap | 345.38M |
| Vol | 78.41K | Avg Vol | 1.21M | EPS | -0.63 | P/E | -11.44 | Forward P/E | -1.03 |
| Beta | 1.05 | Short Ratio | 1.76 | Inst. Own | 74.67% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 5.97 | 200-d Avg | 4.62 | 1yr Est | 1.20 |
Leerink Partners analyst Faisal Khurshid initiates coverage on Shattuck Labs (NASDAQ:STTK) with a
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has received an average recommendation of "Mode
U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and o
Shattuck Labs ($STTK) shares fluctuate after pricing a $75M public offering at $4.00/share. Get the
AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or
Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK), a clinical-stage bi
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or
Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises t
Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NA
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline U
Shattuck Labs Inc. (NASDAQ:STTK) stock is down on Monday following news regarding its lead drug cand
Shattuck Labs' stock tumbles after Phase 1 SL-325 data release despite analyst upgrades, a Buy c
US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech
Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the p
HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Bu
Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ:STTK), a clinical-stage biotechnology company
AUSTIN, TX and DURHAM, NC, June 08, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Co
Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the
AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NA
Citigroup analyst Yigal Nochomovitz upgrades Shattuck Labs (NASDAQ:STTK) from Neutral to Buy and
U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successfu
US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market.
Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and ra
Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.13) per share which met the analyst con
AUSTIN, Texas and DURHAM, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or th
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Shattuck Labs (NASDAQ:STTK) with
Aberdeen Group plc increased its stake in Shattuck Labs, Inc. (NASDAQ: STTK) by 462.1% during the fo
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has earned a consensus recommendation of "Moder
The biotech published its final earnings report and business covering 2025. It posted a slightly nar
AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or
AUSTIN, TX and DURHAM, NC, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has earned a consensus rating of "Hold" from th
AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) was the target of a large increase in short int
An analyst's recommendation upgrade had a major impact on investor sentiment. It's now a buy, accord
AUSTIN, TX and DURHAM, NC, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the
HC Wainwright upgraded Shattuck Labs Inc. (NASDAQ: STTK) from Neutral to Buy, with a price forecast
On Tuesday, 647 companies set new 52-week lows.
On Wednesday, 216 stocks hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
On Monday, 147 stocks hit new 52-week lows.
On Friday, 209 companies set new 52-week lows.
Friday's session saw 466 companies set new 52-week highs.